DNM1P46

mutation — cross-omics
Cross-omicsMUTATION → IMMUNEPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, DNM1P46 mutation is significantly associated with the immune_cell of many other genes, with 1 significant associations in total. BLCA shows the largest number of these associations.

The most reproducible DNM1P46-associated genes across cancer lineages are CD4+ Tcm. Each is linked with DNM1P46 in more than 1 cancer types. Because this analysis shows association rather than direction, both DNM1P46-to-partner and partner-to-DNM1P46 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, CD4+ Tcm grouped by DNM1P46-low versus DNM1P46-high in BLCA.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (DNM1P46→partner) and Y-score (partner→DNM1P46) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLCACD4+ Tcm →+0.037+3.527<.001.03331
Each partner links to its Q-omics profile. Showing the 1 strongest of 1 associations by consensus.

CD4+ Tcm by DNM1P46 expression — BLCA

Box plot of CD4+ Tcm in DNM1P46-low vs DNM1P46-high samples in BLCA.

Explore this box plot interactively →

Exploration